Oracle Investment Management Inc Aspira Women'S Health Inc. Transaction History

Oracle Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.4 - $1.09 $555,495 - $1.51 Million	-1,388,739 Reduced 65.6%	728,100 $428,000
Q1 2022 May 16, 2022	SELL	$0.88 - $1.81 $3.02 Million - $6.21 Million	-3,430,255 Reduced 61.84%	2,116,839 $2.2 Million
Q4 2021 Feb 14, 2022	SELL	$1.63 - $3.43 $5.05 Million - $10.6 Million	-3,100,000 Reduced 35.85%	5,547,094 $9.82 Million
Q4 2020 Feb 16, 2021	SELL	$3.0 - $6.71 $2,040 - $4,562	-680 Reduced 0.01%	8,647,094 $58 Million
Q3 2020 Nov 16, 2020	SELL	$2.54 - $4.56 $4.17 Million - $7.48 Million	-1,640,813 Reduced 15.95%	8,647,774 $26.7 Million
Q2 2020 Aug 14, 2020	BUY	$0.78 - $5.25 $8.03 Million - $54 Million	10,288,587 New	10,288,587 $39.5 Million

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Oracle Investment Management Inc with notifications on news.